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Abstract  
AIM: This study aimed at comparing between bone density using DEXA, serum osteocalcin and 
urinary DPD in obese and non obese prepubertal children.  
METHODS: After taking the consent of eighty children they were subjected to: full examination, 
anthropometric measurements, blood samples were withdrawn to determine serum osteocalcin, Ca, 
Ph, alkaline phosphatase, and urinary DPD. Bone densities, body composition of the whole body 
were examined using DEXA. Data were analyzed using SPSS.  
RESULTS: All anthropometric variables showed significant increase in obese children except for 
height in comparison to control group. Total mass, lean + BMC, lean, fat, area, BMC, BMD and Z 
score of the whole body were significantly increased in obese children. Serum calcium showed 
significant increase while alkaline phosphatase was significantly decreased in obese children. DPD 
showed no significant difference between obese and non obese children. Significant negative 
correlation was found between ca, lean, lean + BMC and total mass. Serum alkaline phosphatase 
showed also a significant negative correlation with (lean + BMC and total mass). Serum osteocalcin 
showed negative significant correlation with area, BMC, BMD, lean and Z score.  
CONCLUSION: Obese children showed significant increase in anthropometric and DEXA 
parameters, increase in serum calcium and significant decrease in serum alkaline phosphatase. 
Osteocalcin was negatively correlated with most of DEXA results. 
 
 
 
 
 
 
 
Introduction 
 
World health organization (WHO) has defined 
obesity as abnormal or excessive fat accumulation 
that may impair health [1].  
Obesity also can be defined as a condition of 
excess fat that results when excess energy has been 
accumulated, and is associated with a large number 
of life threatening disorders. It occurs when energy 
intake exceeds energy expenditure. In other words, it 
is an abnormal growth of adipose tissue due to an 
enlargement of the fat cell size [2]. 
Overweight and obesity are the fifth leading 
risk for global deaths. At least 2.8 million adults die 
each year as a result of being overweight or obese. In 
addition, 44% of the diabetes burden, 23% of the 
ischemic heart disease burden and between 7% and 
41% of certain cancer burdens are attributable to 
overweight and obesity. Body mass index (BMI) is a 
simple index of weight-for-height that is commonly 
used to classify overweight and obesity in adults. It is 
defined as a person's weight in kilograms divided by 
the square of his height in meters (kg/m
2
). WHO has 
defined BMI greater than or equal to 25 as overweight 
and BMI greater than or equal to 30 as obesity [1]. 
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Osteoporosis is a major health problem; it is a 
disease of progressive bone loss associated with 
increased risk of fractures. The disease often 
develops unnoticed over many years, with mild 
symptoms and signs, until fractures occur [3]. It 
develops as a result of imbalance between bone 
resorption and bone formation [4]. Although it is 
considered as a disease of the elderly, there is now 
universal agreement that osteoporosis has pediatric 
origin because if individuals fail to achieve optimal 
peak bone mass (PBM) and strength in childhood and 
adolescence, there is a likelihood of development 
osteoporosis later life [5]. Awareness of osteoporosis 
and its complications is growing; so, there is 
increasing reasons to develop strategies for screening 
in order to target treatment more effectively and 
reduce the number of fractures [3]. 
During the past 10 years, DEXA has emerged 
as a cost-effective, safe and accurate means to 
quantitate skeletal mass. The WHO has adopted 
DEXA derived bone mineral density (BMD) 
measurements to define normal bone, osteopenia and 
osteoporosis [1]. Bone status can be described by 
measuring BMD, which provides information on both 
bone mineral content and bone fragility. Bone mineral 
density measurement, however, does not provide data 
on the rate of bone remodeling. This information is 
obtained, qualitatively, by measuring biochemical 
bone markers. Both measurements complement each 
other and are needed to get a clear understanding of 
bone status. Many physiological and pathological 
processes may influence bone metabolism resulting in 
changes in serum concentration of bone turnover 
markers. Measurements of these parameters offer 
many advantages for investigating skeletal diseases 
in children and adolescents as well as monitoring the 
response to treatment [6]. 
Osteocalcin, the major non-collagenous 
protein, synthesized by osteoblasts plays an important 
role in the regulation of bone growth and in the correct 
deposition of the minerals in the matrix. Its expression 
follows the proliferative phase of osteoplastic 
differentiation, so it can be considered a marker of 
mature osteoblasts. Serum levels of Osteocalcin and 
deoxypyridinoline are not stable throughout our life 
and are greater in infants and children than in adults. 
Peak values occur at puberty [6, 7]. 
The bone resorption marker deoxypyridinoline 
(DPD) reflects the level of osteoclastic activity in the 
bone-remodeling process. Even when BMD is not in 
the osteoporotic range, increases in urine DPD 
indicate increased osteoclastic-bone resorption and 
risk for fracture. Therefore, the spread of obesity 
among prepubertal children and frequent occurrence 
of fractures raises the need for a tool for early 
detection of osteoporosis among obese children [8]. 
The aim of the present study was to compare 
between bone density using DEXA and serum 
Osteocalcin level (as a bone formation marker) beside 
urinary DPD level (as a bone resorption marker) in 
obese and non-obese prepubertal children for early 
detection of osteoporosis in childhood. 
 
 
Subjects and Methods 
 
This case-control study included eighty (80) 
Egyptian children, aged from 6 to10 years, both males 
and females subdivided into 40 cases (obese) and 40 
controls (non-obese). They were enrolled from the 
outpatient clinic of the Institute of Postgraduate 
Childhood Studies, Ain Shams University during the 
period from September 2012 till March 2013, with 
simple exogenous obesity; whose BMI exceeding 95
th
 
percentile for obese and above 5
th
 to less than 85
th
 
percentile for non-obese according to the Egyptian 
Growth Charts [9]. Children with Congenital and 
endocrinal causes of obesity or under treatment with 
corticosteroid therapy were excluded from the study. 
Written informed consent was taken from all patients’ 
parents before enrollment in the study and after full 
explanation of their role in the research. The consent 
was approved by the ethical committee of the National 
Research Center and Institute of postgraduate 
childhood studies, Ain Shams University.  
 
Methods 
All children included in the study were 
subjected to the following: 
1. Full history taking. 
2. Thorough clinical examination. 
- General examination: pulse, blood pressure 
and temperature. 
- Systemic examination: head and neck, 
cardiac, chest, abdominal and neurological 
examination. 
 
3. Anthropometric measurements and 
auxology 
All anthropometric measurements were 
obtained using standardized equipment and following 
the recommendations of the International Biological 
program [10]: body weight, body height, BMI:  
Calculation according to the known formula: BMI = 
weight (kg)/height (m
2
). 
 
4. Laboratory Investigations 
One fasting blood sample will be collected in 
the first visit; (5 cc venous blood samples). Samples 
will be collected in plain vacutainers and 
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subsequently, serum will be separated and stored at -
20
o
C until assay will be performed. While urine is 
collected in a sterile container, centrifugation for 20 
minutes at the speed of 2000-3000 r.p.m., remove 
supernatant. If precipitation appeared, centrifuge 
again. The assay includes: serum Osteocalcin, serum 
calcium, serum inorganic phosphate, serum alkaline 
phosphatise, and urinary deoxypyridinoline (DPD). 
 
5. Bone mineral density assessment 
A real bone mineral density BMD (g/cm
2
) of 
the whole body and the whole body composition 
parameters (whole body bone mineral content (g), 
lean body mass (g), whole body fat (g) and fat %) 
were done to each subject at the Institute of 
Postgraduate Childhood Researches, Ain Shams 
University. All of the parameters mentioned above 
were taken using the Hologic QDR Discovery DEXA 
fan-beam scanner (software v. 12 .1, fast-array 
mode). Calibration stability was monitored using two 
site- specific phantoms (Hologic Anthropomorphic 
Spine and Whole Body phantoms) that are scanned 
weekly. All scans were analyzed using Hologic 
software release 12.3. This software release has 
special features for pediatric scans. The whole body 
analyses use an automatic low bone density detection 
algorithm that increases the sensitivity of finding low 
density bone [11].  
Precautions done before DEXA scanning: - 
Artefacts, including enteric tubes, metallic objects and 
jewellery, were excluded from the image; - We had to 
give sedatives to some children in order to ensure 
child stability all over the scanning time especially 
whole body scan (takes long duration) [12]. 
 
6. Statistical analysis 
Data were analyzed using standard computer 
program SPSS Windows version (17) (SPSS 
Corporation, USA). Descriptions of all data were 
performed as quantitative data and were presented as 
mean, SD (standard deviation), median and range. 
The correlation coefficient (r) was used to interrelate 
the parametric data, and Chi- square test to 
differentiate between percentages cases and controls. 
After analysis a probability p value: P > 0.05 
was considered insignificant; P < 0.05 was considered 
significant; and P < 0.01, <0.001 and < 0.0001were 
considered highly significant. 
 
 
Results 
 
Figure 1 shows distribution of the sample 
according to family history of obesity where we found 
that family history is negative in 42.5% out of 50% in 
controls, while it was positively related in 37.5% out of 
50%in cases. 
 
Figure 1: Distribution of the studied sample according to family 
history of obesity 
 
Figure 2 shows age and anthropometric 
measurements of the studied sample where all 
variables showed significant increase in obese 
children in comparison to control group except for the 
height. 
 
 
Figure 2: Age and anthropometric measurements of the studied 
sample. **, highly significant at p value <0.01; BMI, body mass 
index. 
 
Figures 3, 4, and 5 show comparisons 
between obese and non-obese children in DEXA 
results for the whole body, where all DEXA 
parameters for the whole body showed significant 
increase in obese children more than the non-obese 
children. 
 
Figure 3: Comparison between obese and non-obese children 
concerning total mass (g), lean+BMC (g), lean (g) and fat (g) in 
DEXA results for the whole body. **, p<0.01 highly significant.
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Figure 4: Comparison between obese and non-obese children 
concerning area (cm
2
) and BMC (g) in DEXA results for the whole 
body. **, p<0.01 highly significant; BMC, bone mineral content. 
 
Table 1 and Figures 6 and 7 show 
comparison between obese and non-obese in 
laboratory variables; where calcium showed 
significant increase while alkaline phosphatase 
showed significant decrease in obese children. 
Osteocalcin showed significant decrease in obese 
children, while DPD showed no significant difference 
between obese and non-obese children. 
 
Figure 5: Comparison between obese and non-obese children 
concerning BMD (g/cm
2
) and Z- score in DEXA results for the whole 
body. **, p<0.01 highly significant; BMD, bone mineral density. 
 
 
Discussion 
 
Childhood and adolescence are important 
phases of the human development during which the 
adult bone mass density is determined and therefore, 
problems during this period of life could compromise 
bone health in adulthood. 
Table 1: Comparison between obese and non-obese in 
laboratory parameters 
 Non obese 
N = 40 
Obese 
N = 40 
t 
test 
P value 
Mean ± SD Range Mean ± SD Range 
Ph 6.49±0.67 5.47-7.60 6.27±0.69 4.93-7.47 1.48 >0.05 
OSC 39.06±7.29 23.27-51.20 33.13±11.83 10.60-58.15 2.69 <0.01** 
DPD 306.55±194.81 86.12-652.58 289.02±130.17 112.86-602.27 0.473 >0.05 
Ca 8.48±0.73 6.79-9.32 9.08±0.72 7.96-10.60 3.75 <0.01** 
ALk-ph 70.88±16.67 36.16-94.43 59.98±11.67 23.90-75.58 3.39 <0.01** 
 **, p<0.01highly significant; NS, non- significant; DPD, deoxypyridinoline;  Alk.ph, alkaline 
phosphatise; Ca, Calcium Ph: phosphorus. 
 
Figure 6: Comparison between obese and non-obese children in 
calcium and phosphorus. **, p<0.01 highly significant; NS, non- 
significant; Ca, Calcium; Ph, phosphorus. 
 
Our all anthropometric parameters are 
increased (except for height) in obese children. this 
results goes with that of Cobayashi et al., [13] and 
Abou El-Soud et al., [14], which stated that 
anthropometric measurements are good indicators of 
obesity in children.  
 
Figure 7: Comparison between obese and non-obese children in 
laboratory parameters (DPD-lipid profile-Alkaline phosphatase-OC). 
**, p<0.01 highly significant; NS, non –significant. 
 
Also our results goes in accordance with 
Elkhayat et al., [15], who showed significantly higher 
mean values of weight, weight for age, BMI, waist, hip 
and mid upper arm circumferences, waist: hip ratio as 
well as biceps, triceps, subscapular, suprailiac and 
abdominal skin folds thickness among cases than 
controls. Meanwhile, Salem et al., [16], recommended 
that BMI should be used routinely to screen for 
overweight and obesity in children and adolescents as 
it is easy to use in a clinical setting and correlates with 
subcutaneous and total body fat. 
Table 2: Correlation between DEXA parameters for the whole 
body and Calcium, Phosphorus, Alkaline phosphatase, 
Osteocalcin & deoxypyridinolin 
DEXA  
Parameter 
Ca 
(mg/dl) 
Ph 
(mg/dl) 
Alk.ph. 
(µ/L) 
OSC 
(ng/ml) 
DPD 
(nmol/l) 
r p r p r p R p r p 
Area (cm
2
) 0.051 >0.05 0.057 >0.05 0.070 >0.05 -0.228 <0.05 0.022 >0.05 
BMC(g) 0.115 >0.05 0.217 >0.05 0.094 >0.05 -0.357 <0.01 0.068 >0.05 
BMD (g/cm
2
) 0.109 >0.05 0.168 >0.05 0.118 >0.05 -0.411 <0.01 0.048 >0.05 
Fat(g) 0.004 >0.05 0.160 >0.05 0.214 >0.05 0.030 >0.05 0.020 >0.05 
Lean(g) 0.096 >0.05 -0.246 <0.05 0.135 >0.05 -0.238 <0.05 0.078 >0.05 
Lean + BMC (g) 0.100 >0.05 -0.297 <0.01 -0.232 <0.05 0.209 >0.05 0.078 >0.05 
Total Mass 0.052 >0.05 -0.246 <0.05 -0.238 <0.05 0.097 >0.05 0.032 >0.05 
Z score 0.032 >0.05 0.115 >0.05 0.098 >0.05 -0.292 <0.01 0.130 >0.05 
 *, p<0.05 significant; **, p<0.01highly significant; P>0.05 non-significant, r, correlation 
coefficients. 
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The fact that anthropometric measurements 
are accepted sensitive indicators of growth patterns, 
obesity and health status of a child as stated by 
Chatterjee et al., [17], and the positive relation 
between obesity and body composition especially 
body fat previously shown by
 
Cobayashi et al., [13], 
and Abou El-Soud et al., [14] goes in accordance with 
the results of the present study.  
Regarding bone parameters, our results 
showed that, (BMD, BMC, area, fat, lean, lean + BMC, 
total mass and z-score) for the whole body, hip and 
lumbar areas are greater in obese children, which 
confirm the relationship between them and obesity. All 
of bone measurements are done and gave the same 
results. So we can perform either of them (i.e. 
measuring the whole body alone or with hip or lumbar 
spine). 
Koyama et al., [18]
 
reported that obese 
children had significantly greater fat as well as lean 
compartments, both total and regional and also they 
had higher total BMC and regional BMC values than 
normal - weight children. Also, Clark et al., [19] 
reported that, fat mass is positively related to bone 
area, in view of the strong positive relationship 
between bone size and both BMD and BMC. 
Ellis [20], Hasanoglu et al., [21], and 
Cobayashi et al., [13]
 
found that the median 
prevalence of bone mineral density is twice as 
frequent among post pubertal adolescents who suffer 
from obesity and overweight (69.3%) than among their 
normal weight counterparts (32.1%). 
In contrast with our findings, other 
investigators have reported no difference between 
obese and non-obese stated by Manzoni et al., [22] or 
decreased BMD and BMC in obese children reported 
by Goulding et al., [23].  
 There are several possible mechanisms for 
increased bone mass in childhood obesity. Hormonal 
influences such as increased circulating leptin 
concentrations. Leptin acts as a growth factor on the 
chondrocytes of skeletal growth centers via insulin-like 
growth factor-1 receptor expression and thereby 
potentially contributes to the increased linear growth 
and skeletal mass observed in childhood obesity 
stated by Maor et al., [24]. 
In addition, to increased conversions of 
rostenedione to estrogen may play a role. As it is 
known that, during puberty estrogen promotes accrual 
of bone mass on the cortical endosteal surface and in 
trabecular bone. Also, both androgens and estrogens 
stimulate calcium absorption and retention and result 
in a net positive flow of calcium into bone, which 
contribute to bone accumulation
 
reported by 
Schoenau et al., [25], and Thomas & Burguera [26]. 
Increased biomechanical loading due to 
increased body weight and increased lean muscle 
mechanical forces may also have contributed to the 
increased bone dimensions and mass observed in the 
obese subjects. Increased loading of long bones 
produces the greatest mechanical stresses on the 
sub-periosteal surface and stimulates bone formation 
by sub-periosteal expansion stated by Frost [27]. Also, 
the increase in BMD in relation to increased BMI 
measured by DEXA was explained by Leonardo et al., 
[28] on the basis that DEXA is a two-dimensional 
approach that provides an estimate of density in (gm 
/cm³) which shows only little information about real 
bone strength. 
We propose that the increased BMC in 
childhood obesity results in increased bone strength 
but this increase is not sufficient to overcome the 
significantly greater forces generated when an obese 
child falls on an outstretched arm. This can be 
explained by the increased biochemical loading due to 
increased body weight and increased lean muscle 
mechanical forces that may also have contributed to 
the increased bone dimensions and mass observed in 
the obese subjects. 
Although childhood obesity may result in an 
increased risk of childhood forearm fractures, the 
effect of obesity on life-long fracture risk is unknown. 
Our results showed that, all DEXA parameters 
(BMD, BMC, area, fat, lean, lean + BMC, total mass 
and z-score) for the whole body were positively 
correlated with BMI, weight and height. 
Junior et al., [29] reported a positive 
relationship between body weight and BMD. Indeed, 
obese subjects, from an early age, have an increased 
bone density mainly due to the stress occasioned by 
the increased weight on bone tissue that causes 
deformation and hence leads to bone remodelling. 
This was previously shown by Do Pardo et al., [30], 
2009 and Rhie et al., [31].  
On the contrary, Zamboni et al., [32] 
evaluated the bone mineralization of obese children 
and stated that, obese children had reduced mineral 
density in comparison with normal-weight peers. 
Also, Goulding et al., [23]
 
found that 
overweight and obese children have lower bone area 
and bone mass relative to body weight than their 
leaner peers. 
Cao [33] reported that the decreased bone 
mass with obesity may be due to increased marrow 
adipogenesis at the expense of osteoblastogenesis 
and / or increased osteoclastogenesis because of up 
regulated production of pro inflammatory cytokines 
and/or reduced adiponectin production and / or 
reduced calcium absorption associated with high fat 
intake. 
Ellis [20], Leonardo et al., [28], and Nagasaki 
et al., [34]
 
stated that body weight might improve bone 
mineralization in obese children by increasing the 
mechanical loading on weight-bearing bones. Also, 
Rocher et al., [35] stated that in obese children, the 
skeleton must be stronger than in controls to support 
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their higher body weight. However, the bone mass 
ratio to total body weight was significantly lower in 
obese children in comparison to controls (2.46% ± 
0.46% vs. 3.53% ± 0.46%, p < 0.0001), suggesting 
that the skeleton is not sufficiently resistant to support 
the higher body weight of obese people. 
In this study we measured some important 
laboratory parameters for bone status as calcium, 
phosphorus and alkaline phosphatase in addition to 
serum Osteocalcin and urinary DPD. Both bone 
markers that predict the bone status; were not 
compared to the results of body composition and bone 
parameters obtained by DEXA in any previous 
researches. 
Serum calcium level in our study showed 
significant increase in obese children. This increase in 
serum calcium was previously shown by Zemel et al., 
[36] who found that there is significant increase in 
serum calcium of obese children. 
This can be explained by the excess intake of 
all food supplements by the obese children in this age, 
so it will give us a false interpretation about the 
strength of their bones, as most of us will think that 
they have strong bones although their bones are not 
as strong as it is expected and this increase is in the 
volume only without real increase in strength. 
As for alkaline phosphatase our study showed 
significant decrease in obese children. This decrease 
in serum alkaline phosphatase that was found in our 
obese children also showed a strong negative 
correlation with lean+ BMC, while Marwaha and 
Sripathy [37] found that, among the common bone 
mineral parameters, only serum alkaline phosphatase 
had a significant negative association with BMD. In 
another study by Pettifor and Moodley [38], it was 
shown that serum alkaline phosphatase has a 
negative correlation with BMD and subjects with 
alkaline phosphatase >300 IU had lower BMD than 
those with normal levels. So our results concerning 
the decreased alkaline phosphatase goes in 
accordance with these studies but the strong negative 
correlation differs from a study to another. 
Osteocalcin which is the bone formation 
marker chosen in our study found that its total serum 
levels were significantly lower in obese children. This 
goes in accordance with Wang et al., [39], who found 
the same result in overweight and obese children. 
Again, it was found that osteocalcin is 
negatively correlated with area, BMC, BMD, lean 
mass and z-score, measured for whole body, hip and 
lumbar spine in obese children in comparison to non-
obese children. Similar results were reported Wang et 
al., [39], where they found that serum osteocalcin 
level was negatively correlated with fat percentage 
and visceral fat area. These findings indicate that 
body composition is negatively related to osteocalcin 
levels in obese children. 
Another study by Bonofiglio et al., [40]
 
conducted in adolescent girls had documented that 
serum osteocalcin was negatively correlated with 
BMD at ultra-distal and proximal radius of the forearm. 
It is known that, the bone resorption marker 
(deoxypyridinoline DPD) reflects the level of 
osteoclastic activity in the bone-remodelling process 
and a higher risk for osteoporotic hip fracture, 
independent of BMD. Even when BMD is not in the 
osteoporotic range, increases in urine DPD indicate 
increased osteoclastic-bone resorption and risk for 
fracture as stated by McCormic et al., [8]. 
In the present study, the urinary DPD which 
was used as bone turnover marker showed no 
significant difference between obese and non-obese 
groups. So, we can use osteocalcin as an early 
predictor of osteoporosis in obese children to avoid 
continuation of the problem of osteoporosis in the 
adult period especially in pre and post-menopausal 
females. While for the urinary DPD, as it did not give 
us any significant data either in obese or non-obese 
children in addition to its high price, so we do not 
recommend the use of the urinary DPD as a bone turn 
over marker in this early age. 
In conclusion, obese children have increased 
anthropometric and DEXA parameters which were 
positively correlated with BMI, weight, height and lipid 
profile except for HDL. Obese children also showed 
significant increase in serum calcium and significant 
decrease in alkaline phosphatase. Osteocalcin was 
found to be negatively correlated with most of DEXA 
results in obese children in comparison to non-obese 
children. While the urinary DPD, showed no significant 
difference between obese and non-obese groups. 
Recommendations: Preventive measures 
should be implemented quite early so that obesity and 
its co morbidities can be controlled through 
participation in physical activities and through an 
adequate diet. 
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